Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/27729
Full metadata record
DC FieldValueLanguage
dc.contributor.authorROBIJNS, Jolien-
dc.contributor.authorLODEWIJCKX, Joy-
dc.contributor.authorMEBIS, Jeroen-
dc.date.accessioned2019-02-13T15:41:40Z-
dc.date.available2019-02-13T15:41:40Z-
dc.date.issued2019-
dc.identifier.citationCURRENT OPINION IN ONCOLOGY, 31 (4), p. 291-298-
dc.identifier.issn1040-8746-
dc.identifier.urihttp://hdl.handle.net/1942/27729-
dc.description.abstractPurpose of review The number of clinical trials on the use of photobiomodulation therapy (PBMT) for the management of cancer therapy-related complications is growing steadily. One of the side-effects that is under investigation is acute radiodermatitis (ARD), an inflammatory skin reaction caused by radiotherapy. In this review, an overview is given on the state of art of the application of PBMT for the prevention and management of ARD. Recent findings Up to now about seven clinical trials have been performed, investigating the use of PBMT in the prevention and/or management of ARD. Results demonstrate that PBMT can effectively reduce the incidence of severe ARD, decrease the accompanying pain, and improve the patients’ quality of life. Moreover, the technique seems to be well tolerated in oncologic patients. Summary On the basis of the available evidence, there could be a strong recommendation to use PBMT in the prevention and management of ARD in cancer patients.-
dc.description.sponsorshipThis research is part of the Limburg Clinical Research Program (LCRP) UHasselt-ZOL-Jessa, financially supported by the foundation Limburg Sterk Merk, province of Limburg, Flemish government, Hasselt University, Ziekenhuis Oost-Limburg, and Jessa Hospital. Additionally, this research is supported by Kom op Tegen Kanker, Limburgs Kankerfonds, and ASA Srl.-
dc.language.isoen-
dc.subject.otherlow-level light therapy; photobiomodulation therapy; radiodermatitis; radiotherapy; supportive care-
dc.titlePhotobiomodulation therapy for acute radiodermatitis-
dc.typeJournal Contribution-
dc.identifier.epage298-
dc.identifier.issue4-
dc.identifier.spage291-
dc.identifier.volume31-
local.bibliographicCitation.jcatA1-
dc.description.notesRobijns, J (reprint author), Hasselt Univ, Fac Med & Life Sci, Martelarenlaan 42, B-3500 Hasselt, Belgium. Jolien.robijns@uhasselt.be-
local.type.refereedRefereed-
local.type.specifiedArticle-
local.classdsPublValOverrule/author_version_not_expected-
dc.identifier.doi10.1097/CCO.0000000000000511-
dc.identifier.isi000480731200007-
item.contributorROBIJNS, Jolien-
item.contributorLODEWIJCKX, Joy-
item.contributorMEBIS, Jeroen-
item.validationecoom 2020-
item.fullcitationROBIJNS, Jolien; LODEWIJCKX, Joy & MEBIS, Jeroen (2019) Photobiomodulation therapy for acute radiodermatitis. In: CURRENT OPINION IN ONCOLOGY, 31 (4), p. 291-298.-
item.accessRightsRestricted Access-
item.fulltextWith Fulltext-
crisitem.journal.issn1040-8746-
crisitem.journal.eissn1531-703X-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Robijns_2019_Review_Photobiomodulation.pdf
  Restricted Access		Published version272.7 kBAdobe PDFView/Open    Request a copy
Show simple item record

SCOPUSTM   
Citations

3
checked on Sep 2, 2020

WEB OF SCIENCETM
Citations

13
checked on Apr 24, 2024

Page view(s)

134
checked on Sep 7, 2022

Download(s)

146
checked on Sep 7, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.